PWP
GH icon

Pursue Wealth Partners’s Guardant Health GH Stock Holding History

Pursue Wealth Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,634
Closed -$194K – 159
2022
Q1 		$194K Hold
2,634
– – 0.08% 133
2021
Q4 		$263K Buy
+2,634
New +$272K 0.1% 124

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Pursue Wealth Partners's GH Position: Q2 2022 in Review

Pursue Wealth Partners sold out of Guardant Health (GH) in Q2 2022, closing a stake of 2,634 shares — an estimated $194K sold.

Pursue Wealth Partners first reported a position in GH in Q4 2021 and held it in 2 quarters. The position peaked at $263K in Q4 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Pursue Wealth Partners reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Pursue Wealth Partners sold 2,634 Guardant Health shares in Q2 2022, an estimated $194K.
  • Pursue Wealth Partners first reported a position in Guardant Health in Q4 2021 and held it in 2 quarters.
  • Pursue Wealth Partners's Guardant Health position peaked at $263K in Q4 2021.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Pursue Wealth Partners's 13F filing for Q2 2022, filed 11 Aug 2022.